BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20226523)

  • 1. Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.
    Belada D; Smolej L; Stepánková P; Králícková P; Freiberger T
    Leuk Res; 2010 Sep; 34(9):e232-4. PubMed ID: 20226523
    [No Abstract]   [Full Text] [Related]  

  • 2. Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab.
    Bard S; Paravisini A; Avilés-Izquierdo JA; Fernandez-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2008 Dec; 144(12):1662-3. PubMed ID: 19075161
    [No Abstract]   [Full Text] [Related]  

  • 3. Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome.
    Kashef MA; Kashef S; Handjani F; Karimi M
    Pediatr Hematol Oncol; 2006; 23(1):59-63. PubMed ID: 16326414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma on the back of a patient with AIDS: successful treatment by the CD20 monoclonal antibody rituximab.
    Voigtländer C; Harrer T; Schneider L; Schulze-Koops H; Niedobitek G; Lüftl M
    Int J Dermatol; 2005 Nov; 44(11):976-8. PubMed ID: 16336543
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diffuse large B-cell lymphoma.
    Coiffier B
    Curr Hematol Rep; 2005 Jan; 4(1):7-14. PubMed ID: 15610654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.
    Nakai S; Masaki T; Shintani T; Deguchi A; Kimura Y; Himoto T; Kurokohchi K; Watanabe S; Kuriyama S
    Oncol Rep; 2005 Jun; 13(6):1065-8. PubMed ID: 15870922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mantle cell lymphoma associated with hyper-IgE syndrome].
    Takimoto Y; Imanaka F; Nanba K
    Rinsho Ketsueki; 1996 Dec; 37(12):1400-4. PubMed ID: 8997129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in a patient with Hyper-IgE syndrome.
    Trendelenburg M; Schifferli JA
    Arch Dermatol; 2007 Jun; 143(6):807-8. PubMed ID: 17576959
    [No Abstract]   [Full Text] [Related]  

  • 13. A rare cause of gastrointestinal bleeding in a patient with hyper-IgE syndrome.
    Götzberger M; Schlesinger A; Dauer M; Heldwein W; Jansson A; Renner E; Belohradsky BH
    Gut; 2004 Oct; 53(10):1430, 1436. PubMed ID: 15361489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of diffuse large B-cell lymphoma].
    Gleissner B; Zwick C; Pfreundschuh M
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual psoriasiform lesions in a patient with Hyper-IgE syndrome.
    Li XL; Geng SM; Lei XB; Xiao SX; Liu Y; Peng ZH
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):424-6. PubMed ID: 17309489
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pure red cell aplasia successfully treated with rituximab in a patient with relapsed diffuse large B-cell lymphoma].
    Suzuki T; Kumagai T; Kitano A; Kubo H; Tabata M; Kimura Y; Miura O; Imai Y
    Rinsho Ketsueki; 2007 Jan; 48(1):67-70. PubMed ID: 17313080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
    Ozgönenel B; Moonka D; Savaşan S
    Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
    [No Abstract]   [Full Text] [Related]  

  • 19. Fungal pulmonary abscess in an adult secondary to hyperimmunoglobulin E (Job's) syndrome.
    Hall RA; Salhany KE; Lebel E; Bavaria JE; Kaiser LR
    Ann Thorac Surg; 1995 Mar; 59(3):759-61. PubMed ID: 7887732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fournier gangrene associated with hyper IgE syndrome (Job syndrome).
    Hori J; Yamaguchi S; Watanabe M; Osanai H; Hori M
    Int J Urol; 2008 Apr; 15(4):372-3. PubMed ID: 18380833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.